Divis Laboratories Ltd Share Price – NSE  / BSE

Pharmaceuticals, Mid Cap

Divis Laboratories Ltd rose for a fifth straight session today. The stock is quoting at Rs 6075.75, up 1.29% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 1.58% on the day, quoting at 24284.95. The Sensex is at 80244.25, up 1.42%. Divis Laboratories Ltd has added around 4.49% in last one month.

Meanwhile, Nifty Pharma index of which Divis Laboratories Ltd is a constituent, has added around 2.89% in last one month and is currently quoting at 21962.05, up 1.07% on the day. The volume in the stock stood at 1.57 lakh shares today, compared to the daily average of 4.48 lakh shares in last one month.

The benchmark November futures contract for the stock is quoting at Rs 6100.3, up 1.47% on the day. Divis Laboratories Ltd is up 61.58% in last one year as compared to a 22.1% gain in NIFTY and a 39.6% gain in the Nifty Pharma index.

The PE of the stock is 86.7 based on TTM earnings ending September 24.

Powered by Capital Market - Live News

Total income grew by 22.51% year on year (YoY) to Rs 2,444 crore in the quarter ended 30 September 2024.

Profit before tax for the quarter was at Rs 722 crore, up 53.94% from Rs 469 crore reported in the same period a year ago.

Total expenses stood at Rs 1,722 crore in second quarter of FY25, up 12.84% on YoY basis. Cost of material consumed was at Rs 976 crore (up 37.27% YoY) and employee benefit expenses stood at Rs 304 crore (up 14.29% YoY) during the period under review.

Forex gain for the current quarter amounted to Rs 29 crore as against a gain of Rs 11 crore posted in Q2 FY24.

On half yearly basis, the company’s net profit climbed 33.52% to Rs 940 crore on 20.86% rise in revenue from operations to Rs 4,456 crore in H1 FY25 over H1 FY24.

Forex gain for the six month period amounted to Rs 28 crore as against a gain of Rs 14 crore posted in same period a year ago.

Divi’s Laboratories is engaged in the manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients.

Shares of Divi’s Laboratories declined 0.34% to end at Rs 5,938.15 on Friday, 8 November 2024.

Powered by Capital Market - Live News

Net profit of Divi's Laboratories rose 46.55% to Rs 510.00 crore in the quarter ended September 2024 as against Rs 348.00 crore during the previous quarter ended September 2023. Sales rose 22.47% to Rs 2338.00 crore in the quarter ended September 2024 as against Rs 1909.00 crore during the previous quarter ended September 2023.

Powered by Capital Market - Live News

Divis Laboratories will hold a meeting of the Board of Directors of the Company on 9 November 2024

Powered by Capital Market - Live News